For example, the vast majority of Polycythemia vera patients carry gain-of function mutations in Janus kinase 2 (JAK2 V617F) [9], while a hallmark of chronic myeloid leukemia (CML) is the generation of BCR-ABL fusion proteins [10]. The gene discussed is JAK2; the disease is acquired polycythemia vera.